Adalimumab/infliximab/natalizumabHepatosplenic T-cell lymphoma: 25 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1385卷 / 1期

关键词：

Rheumatoid Arthritis; Methotrexate; Ulcerative Colitis; Infliximab; Adalimumab;

D O I：

10.2165/00128415-201213850-00013

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：6 / 6

相关论文

共 50 条

[41] Adalimumab/infliximab/vedolizumabNon-responsiveness: 10 case reports
Reactions Weekly, 2022, 1896 (1) : 22 - 22
[42] Adalimumab/infliximab/tofacitinibAcquired disseminated histoplasmosis: 16 case reports
Reactions Weekly, 2018, 1692 (1) : 21 - 21
[43] Adalimumab/infliximab/rituximabVarious hypersensitivity reactions: 4 case reports
Reactions Weekly, 2014, 1530 (1) : 21 - 21
[44] Adalimumab/etanercept/infliximab/rituximabVarious toxicities: 33 case reports
Reactions Weekly, 2015, 1550 (1) : 12 - 12
[45] Adalimumab/azathioprine/infliximabHepatosplenic T cell lymphoma: case report
Reactions Weekly, 2009, 1269 (1) : 5 - 5
[46] Nasal NK/T-cell lymphoma in the paediatric population. two case reports
Zeglaoui, I.
Belcadhi, M.
Sriha, B.
Bouzouita, K.
B-ENT, 2009, 5 (02): : 119 - 123
[47] Subcutaneous panniculitis-like T-cell lymphoma. Two case reports
Wagner, G.
Rose, Ch.
Meyer, V.
Klemke, C. -D.
Back, W.
Sachse, M. M.
HAUTARZT, 2016, 67 (05): : 397 - 402
[48] Photodynamic therapy of cutaneous T-cell lymphoma in special locations: two case reports
Eich, D
Eich, HT
Otte, HG
Ghilescu, V
Stadler, R
HAUTARZT, 1999, 50 (02): : 109 - 114
[49] AZD-1222Recurrence of cutaneous T-cell lymphoma: 2 case reports
Reactions Weekly, 2022, 1894 (1) : 68 - 68
[50] Adalimumab/infliximab/purinesSquamous cell carcinoma, basal cell carcinoma and malignant melanoma: 3 case reports
Reactions Weekly, 2021, 1847 (1) : 22 - 22

← 1 2 3 4 5 →